Altered expression of chemoattractant receptor–homologous molecule expressed on TH2 cells on blood basophils and eosinophils in patients with chronic spontaneous urticaria - 07/01/16
Doi : 10.1016/j.jaci.2015.06.004
| Supported through self-funds and AstraZeneca. AstraZeneca had no involvement in the design of this study, data collection, analysis or interpretation of the results, writing of this report, or decision to submit this report for publication. |
|
| Disclosure of potential conflict of interest: S. S. Saini has received research support from AstraZeneca, Novartis, the National Institutes of Health/National Institute of Allergy and Infectious Diseases, and ITN; has received consultancy fees from Ono, Novartis, Genentech, and Medimmune; and has received royalties from UpToDate. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2015
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 137 - N° 1
P. 304 - janvier 2016 Retour au numéro
Article précédent
- Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism
- Emma Guttman-Yassky, Benjamin Ungar, Shinji Noda, Maria Suprun, Anjali Shroff, Riana Dutt, Saakshi Khattri, Michelle Min, Yasaman Mansouri, Xiuzhong Zheng, Yeriel D. Estrada, Giselle K. Singer, Mayte Suarez-Farinas, James G. Krueger, Mark G. Lebwohl
- Evaluation of antithymocyte globulin pharmacokinetics and pharmacodynamics in children
- Naïm Bouazza, Saik Urien, Bénédicte Neven, Despina Moshous, Jennifer Nisoy, Aurélie Gabrion, Marina Cavazzana, Stéphane Blanche, Jean-Marc Tréluyer, Fabien Touzot
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?